Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


How Pharma Firms Using AI Should Navigate Regulatory Submissions

Executive Summary

Global regulators have yet to develop hard and fast rules for the use of artificial intelligence in drug development. Until they do, pharma companies should be guided by transparency and best practice principles when preparing submissions, a consultant says.

You may also be interested in...

Rising Up In Biopharma: Optimism, AI And Perseverance

Ahead of In Vivo’s 2024 Rising Leaders list being revealed in April, a panel of biopharma leaders discussed industry trends and biopharma career stories at BIO-Europe Spring.

European Parliament Adopts Landmark AI Act

Members of the European Parliament (MEPs) have voted overwhelmingly in favor of the Artificial Intelligence Act, which will introduce strict requirements for AI systems used in high-risk settings such as health care.

EMA Opens Discussion On Appropriate Use Of AI In Drug Lifecycle

The European Medicines Agency is inviting feedback on a draft reflection paper that outlines the scientific principles companies should follow when using AI tools in the medicinal product lifecycle.

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts